Gotham Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,391
Closed -$400K 1354
2023
Q3
$400K Buy
+19,391
New +$492K 0.01% 1031
2023
Q1
Sell
-13,029
Closed -$362K 1340
2022
Q4
$362K Sell
13,029
-1,578
-11% -$47K 0.01% 993
2022
Q3
$448K Sell
14,607
-678
-4% -$22K 0.01% 874
2022
Q2
$450K Buy
+15,285
New +$400K 0.01% 816
2021
Q4
Sell
-5,317
Closed -$268K 1157
2021
Q3
$268K Sell
5,317
-4,222
-44% -$238K 0.01% 878
2021
Q2
$748K Sell
9,539
-15,702
-62% -$971K 0.03% 572
2021
Q1
$1.44M Buy
25,241
+17,646
+232% +$1.18M 0.06% 367
2020
Q4
$636K Buy
+7,595
New +$459K 0.02% 659

Other funds holding DNLI